This brief review intends to highlight how heterogeneous the world is regarding cardiovascular mortality and overall use of nuclear cardiology, especially in the developing world where mortality remains high. This was one of the important topics discussed during ASNC2017 in Kansas City, USA. Despite the challenges, appropriate use of nuclear cardiology could be helpful to estimate risk and guide patient management, bringing opportunities to the developing world. In addition, we briefly list key issues which could serve as a guide to foster the development of nuclear cardiology, including the imperative need to avoid unnecessary revascularizations, which might be even more challenging with increased use of non-invasive diagnosis of disease by computed tomography. When we look at nuclear cardiology, on the most widely used technique for risk stratification, we observe that there is, in general, low utilization where mortality is high and the opposite where mortality is low (2). This does not mean directly that the use of nuclear cardiology decreases mortality but could serve as one of the markers on how investments in health care can lead to decreased mortality and increased longevity, probably due to a combination of prevention associated with management guided by one or another form of technology.
When we look at nuclear cardiology, on the most widely used technique for risk stratification, we observe that there is, in general, low utilization where mortality is high and the opposite where mortality is low (2). This does not mean directly that the use of nuclear cardiology decreases mortality but could serve as one of the markers on how investments in health care can lead to decreased mortality and increased longevity, probably due to a combination of prevention associated with management guided by one or another form of technology.
What is needed to develop and foster the growth of nuclear cardiology?
Regarding the practice and utilization of nuclear cardiology we can say that the world is heterogeneous in many different forms, varying form the degree of training of personal, financial resources to invest in technology and level of information of referring physicians regarding the clinical value of different diagnostic modalities. Table 1 and 1B exemplify such a case.
Conclusion
Despite the challenges present today to develop nuclear cardiology in many countries, the aspects on table 1 can serve as a guide to successful development of this technology in many parts of the world. The significant problem of mortality due to CAD, especially the premature deaths that still occur in excess in the developing world bring to nuclear cardiology an opportunity to be part of the solution to better stratify risk of patients and guide management. The growth of CCTA utilization in many parts of the world is another opportunity
Vitola NC in Developing World
Ann Nucl Cardiol 2018；4（1） ：139-141 -140 - Table 1 Key issues to develop nuclear cardiology (NC) ・Professionals need to be useful and deliver quality work ・Professionals should keep up to date with current knowledge ・Participate in cardiology meetings and clinical discussions ・Explore opportunities to participate in regional scientific meetings and deliver talks ・Build useful and friendly relationship with referring physicians ・Know the strenghts and weaknessess of NC ・Explore scientific cooperation with other specialities/institutions ・Explore opportunities to do research and publish ・If possible be proactive helping healthcare providers (public/private) with protocols for nuclear cardiology, bringing to the patient's evaluation the so needed functional information necessary to guide treatment and to help the cardiologist to make important decisions of whether to maintain the patient in clinical management, as shown on figures 1A and 1B or to send the patient to revascularization.
